H Kim, Y Ahn - Diabetes, 2004 - Am Diabetes Assoc Type 2 diabetes develops in the context of both insulin resistance and β-cell
failure. Thiazolidinediones are a class of antidiabetic agents that are known to
improve insulin sensitivity in various animal models of diabetes. The ... Cited by 29 - Related articles - BL Direct - All 7 versions
SS Im, JW Kim, TH Kim, XL Song, SY Kim, H … - Exp Mol Med, 2005 - e-emm.or.kr 1Department of Biochemistry and Molecular Biology 2Center for Chronic Metabolic
Disease Research 3Institute of Genetic Science 4Brain Korea 21 Project for
Medical Science, Korea Yonsei University College of Medicine 134 ... Cited by 11 - Related articles - View as HTML - All 8 versions
H Kim, JY Cha, SY Kim, J Kim, KJ Roh, JK … - Diabetes, 2002 - Am Diabetes Assoc Thiazolidinediones, synthetic ligands of peroxisomal proliferator-activated
receptor-γ (PPAR-γ), improve peripheral insulin sensitivity and
glucose-stimulated insulin secretion in pancreatic β-cells. To explore the ... Cited by 61 - Related articles - BL Direct - All 6 versions
[CITATION] Weissa Endurance training-induced changes in the insulin response to oral glucose are …
S Kim, H Kim, SK Park, SS Im, T Li, HG Cheon … - Diabetes, 2004 - Am Diabetes Assoc Thiazolidinediones (TZDs), synthetic ligands of peroxisome
proliferator-activated receptor (PPAR)-γ, are known to decrease hepatic glucose
production and increase glycogen synthesis in diabetic animals. Recently it ... Cited by 21 - Related articles - BL Direct - All 5 versions
WS Zawalich, G Tesz, KC Zawalich - Metabolism, 2003 - Elsevier When stimulated with 6 mmol/L glucose, a minimal, transient insulin secretory
response was observed from perifused rat islets. The inclusion of 5 μmol/L
nateglinide significantly amplified release. Elevating glucose to 8 or 10 ... Cited by 5 - Related articles - All 9 versions
